These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 7819046)
1. Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines. Eijdems EW; de Haas M; Timmerman AJ; Van der Schans GP; Kamst E; de Nooij J; Astaldi Ricotti GC; Borst P; Baas F Br J Cancer; 1995 Jan; 71(1):40-7. PubMed ID: 7819046 [TBL] [Abstract][Full Text] [Related]
2. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I. Prost S; Riou G Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551 [TBL] [Abstract][Full Text] [Related]
4. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209 [TBL] [Abstract][Full Text] [Related]
5. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555 [TBL] [Abstract][Full Text] [Related]
6. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells. Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713 [TBL] [Abstract][Full Text] [Related]
7. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. de Jong S; Zijlstra JG; de Vries EG; Mulder NH Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417. Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183 [TBL] [Abstract][Full Text] [Related]
9. Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. Zwelling LA; Hinds M; Chan D; Mayes J; Sie KL; Parker E; Silberman L; Radcliffe A; Beran M; Blick M J Biol Chem; 1989 Oct; 264(28):16411-20. PubMed ID: 2550442 [TBL] [Abstract][Full Text] [Related]
10. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]. Matsumoto Y; Takano H; Nagao S; Iglesias A; Fojo T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2265-9. PubMed ID: 9422071 [TBL] [Abstract][Full Text] [Related]
11. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. Adlakha RC; Ashorn CL; Chan D; Zwelling LA Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251 [TBL] [Abstract][Full Text] [Related]
12. Combined modalities of resistance in etoposide-resistant human KB cell lines. Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393 [TBL] [Abstract][Full Text] [Related]
13. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line. Feldhoff PW; Mirski SE; Cole SP; Sullivan DM Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338 [TBL] [Abstract][Full Text] [Related]
14. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage. Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973 [TBL] [Abstract][Full Text] [Related]
15. [Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]. Matsumoto Y; Morisaki K; Kunishio K; Nagao S; Takano H; Fojo T Gan To Kagaku Ryoho; 1998 Jul; 25(8):1145-9. PubMed ID: 9679576 [TBL] [Abstract][Full Text] [Related]
16. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine. Sorensen M; Sehested M; Jensen PB Mol Pharmacol; 1999 Mar; 55(3):424-31. PubMed ID: 10051525 [TBL] [Abstract][Full Text] [Related]
17. Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2. Matsumoto Y; Tamiya T; Nagao S J Med Invest; 2005 Feb; 52(1-2):41-8. PubMed ID: 15751272 [TBL] [Abstract][Full Text] [Related]
18. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform. Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608 [TBL] [Abstract][Full Text] [Related]
19. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells. Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033 [TBL] [Abstract][Full Text] [Related]
20. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]